TGFB1 and hepatocellular carcinoma: To validate whether TGF‐β isoforms might interrupt intracellular HCV replication after virus entry, we first applied GS4.3 cells, a human hepatoma Huh7 cell line, which carried an HCV sub‐genomic replicon I 377‐3’del.S.24